David A. Pierce

2018

In 2018, David A. Pierce earned a total compensation of $2.7M as Executive Vice President and President, MedSurg at Boston Scientific.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$146,487
Non-Equity Incentive Plan$500,181
Option Awards$375,000
Salary$538,996
Stock Awards$1,146,533
Other$24,223
Total$2,731,420

Pierce received $1.1M in stock awards, accounting for 42% of the total pay in 2018.

Pierce also received $146.5K of change in pension value and nonqualified deferred compensation earnings, $500.2K in non-equity incentive plan, $375K in option awards, $539K in salary and $24.2K in other compensation.

Rankings

In 2018, David A. Pierce's compensation ranked 4,280th out of 14,244 executives tracked by ExecPay. In other words, Pierce earned more than 70.0% of executives.

ClassificationRankingPercentile
All
4,280
out of 14,244
70th
Division
Manufacturing
1,587
out of 5,765
73rd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
200
out of 849
76th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
111
out of 547
80th
Industry
Surgical and Medical Instruments and Apparatus
71
out of 348
80th

Pay ratio

David A. Pierce's Pay$2,731,420
Median Employee's Pay$62,447
Pay Ratio

44

to 1

In 2018, the annual total compensation of David A. Pierce was $2,731,420.

The annual total compensation of the median employee at Boston Scientific was $62,447.

The ratio of David A. Pierce's pay to the pay of median employee was therefore 44 to one.

Source: SEC filing on March 27, 2019.

Pierce's colleagues

We found four more compensation records of executives who worked with David A. Pierce at Boston Scientific in 2018.

2018

Michael Mahoney

Boston Scientific

Chief Executive Officer

2018

Joseph Fitzgerald

Boston Scientific

Executive Vice President and President, Rhythm Management

2018

Daniel Brennan

Boston Scientific

Chief Financial Officer

2018

Kevin Ballinger

Boston Scientific

Executive Vice President and President, Interventional Cardiology

News

You may also like